ResearchMoz added Latest Research Report titled " Biotherapeutics Cell Line Development Market (by Process, CLD Option and by Geography): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022 " to it's Large Report database.
With the increasing number of recombinant protein therapeutics gaining approval by the U.S. Food and Drug Administration (FDA) annually, there is an increase in the demand of cell lines for production of these biotherapeutics. From 2006 to 2011 an average of 15 novel recombinant protein therapeutics and in 2014, 11 novel recombinant protein therapeutics have been approved by US FDA. About forty-seven monoclonal antibody products have been approved in the U.S., Europe and other global markets, of which over 60% were produced in mammalian cell culture. Moreover, the rise in the geriatric population coupled with prevalence of diseases is one of the major factors driving the demand for cell line development for biotherapeutics. The increasing demand for monoclonal antibodies across the globe boosts the market growth. In addition, the increasing number of initiatives taken by the government of various countries by funding the life science research and development is expected to propel this market in coming years.
Request for Sample PDF of Premium Research Report with TOC: https://www.researchmoz.us/enquiry.php?type=S&repid=531402
The global biotherapeutics cell line development market is segmented by process, by cell line development option and by geography. The market by process segment has been sub-segmented as transfection and single cell cloning. The single cell cloning market is further sub-segmented by method into manual limited dilution cloning, FACS, ClonePix and Others. The market by CLD option is segmented as In-house, outsource, hybrid and do-it-yourself. The ClonePix accounted for the largest market share of 37.4% in 2014. Geographically, the market has been studied and estimated for five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. The market overview section includes market attractiveness analysis, by geography, to provide a thorough analysis of the overall competitive scenario in the global biotherapeutics cell line development market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape.
Browse more details @ https://www.researchmoz.us/biotherapeutics-cell-line-development-market-by-process-cld-option-and-by-geography-global-industry-analysis-size-share-growth-trends-and-forecast-2015-2022-report.html
Table of Contents
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Biotherapeutics Cell Line Development Market
2.2 Comparative Analysis: Global Biotherapeutics Cell Line Development Market, by Geography, 2014 & 2022
Chapter 3 Biotherapeutics Cell Line Development Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Biotherapeutics Cell Line Development Sites: Qualitative Analysis, 2014
3.4 Market Attractiveness Analysis: Biotherapeutics Cell Line Development Market, by Geography, 2014
3.5 Competitive Landscape: FACS Market
3.5.1 Market Share by Revenue, by Key Players, 2014 (Value %)
Chapter 4 Global Biotherapeutics Cell Line Development Market Revenue, by Process, 2014 – 2022 (USD Million)
4.1 Introduction
4.2 Transfection & Selection
4.3 Single Cell Cloning
4.3.1 Manual Limited Dilution Cloning (e.g. Single Cell Imagers such as CloneSelect, etc.)
4.3.2 FACS
4.3.3 ClonePix
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
With the increasing number of recombinant protein therapeutics gaining approval by the U.S. Food and Drug Administration (FDA) annually, there is an increase in the demand of cell lines for production of these biotherapeutics. From 2006 to 2011 an average of 15 novel recombinant protein therapeutics and in 2014, 11 novel recombinant protein therapeutics have been approved by US FDA. About forty-seven monoclonal antibody products have been approved in the U.S., Europe and other global markets, of which over 60% were produced in mammalian cell culture. Moreover, the rise in the geriatric population coupled with prevalence of diseases is one of the major factors driving the demand for cell line development for biotherapeutics. The increasing demand for monoclonal antibodies across the globe boosts the market growth. In addition, the increasing number of initiatives taken by the government of various countries by funding the life science research and development is expected to propel this market in coming years.
Request for Sample PDF of Premium Research Report with TOC: https://www.researchmoz.us/enquiry.php?type=S&repid=531402
The global biotherapeutics cell line development market is segmented by process, by cell line development option and by geography. The market by process segment has been sub-segmented as transfection and single cell cloning. The single cell cloning market is further sub-segmented by method into manual limited dilution cloning, FACS, ClonePix and Others. The market by CLD option is segmented as In-house, outsource, hybrid and do-it-yourself. The ClonePix accounted for the largest market share of 37.4% in 2014. Geographically, the market has been studied and estimated for five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. The market overview section includes market attractiveness analysis, by geography, to provide a thorough analysis of the overall competitive scenario in the global biotherapeutics cell line development market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape.
Browse more details @ https://www.researchmoz.us/biotherapeutics-cell-line-development-market-by-process-cld-option-and-by-geography-global-industry-analysis-size-share-growth-trends-and-forecast-2015-2022-report.html
Table of Contents
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Biotherapeutics Cell Line Development Market
2.2 Comparative Analysis: Global Biotherapeutics Cell Line Development Market, by Geography, 2014 & 2022
Chapter 3 Biotherapeutics Cell Line Development Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Biotherapeutics Cell Line Development Sites: Qualitative Analysis, 2014
3.4 Market Attractiveness Analysis: Biotherapeutics Cell Line Development Market, by Geography, 2014
3.5 Competitive Landscape: FACS Market
3.5.1 Market Share by Revenue, by Key Players, 2014 (Value %)
Chapter 4 Global Biotherapeutics Cell Line Development Market Revenue, by Process, 2014 – 2022 (USD Million)
4.1 Introduction
4.2 Transfection & Selection
4.3 Single Cell Cloning
4.3.1 Manual Limited Dilution Cloning (e.g. Single Cell Imagers such as CloneSelect, etc.)
4.3.2 FACS
4.3.3 ClonePix
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
No comments:
Post a Comment